Citations (146)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (56)
Seon Cheol Park, Narongkorn Saiphoklang, Jonathan Phillips, May-Lin Wilgus, Russell G Buhr, Donald P Tashkin, Christopher B Cooper & Igor Barjaktarevic. (2023) Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1475-1486.
Read now
Read now
Janelle Yorke, Naimat Khan, Adam Garrow, Sarah Tyson, Dave Singh, Jorgen Vestbo & Paul W Jones. (2022) Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2289-2299.
Read now
Read now
Clarus Leung & Don D. Sin. (2022) Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 23:12, pages 1359-1362.
Read now
Read now
Samuel De Bontridder, Jean-Louis Corhay, Christel Haenebalcke, Frederic Fievet, Isabelle Etienne & Eef Vanderhelst. (2022) Correlation of symptoms and physical activity level in chronic obstructive pulmonary disease patients: results from the observational SPACE study. Acta Clinica Belgica 77:3, pages 671-678.
Read now
Read now
Florin Mihaltan, Ruxandra-Mioara Rajnoveanu, Oana Cristina Arghir, Silviu Alecu & Paraschiva A Postolache. (2021) High 24-Hour Respiratory Symptoms and Low Physical Activity in the Stable COPD Romanian Cohort of SPACE Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2533-2544.
Read now
Read now
Silvia Uccelli, Laura Pini, Damiano Bottone, Piera Ranieri, Nicla Orzes & Claudio Tantucci. (2020) Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2549-2558.
Read now
Read now
Tian Sun, Xiaoyun Li, Wei Cheng, Yating Peng, Yiyang Zhao, Cong Liu, Yuqin Zeng, Yan Chen, Shan Cai & Ping Chen. (2020) The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1899-1907.
Read now
Read now
Tanja Plate, Felix W Friedrich & Jutta Beier. (2020) Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1335-1347.
Read now
Read now
Alberto Braghiroli, Fulvio Braido, Alessio Piraino, Paola Rogliani, Pierachille Santus & Nicola Scichilone. (2020) Day and Night Control of COPD and Role of Pharmacotherapy: A Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1269-1285.
Read now
Read now
Line Hust Storgaard, Ulla Møller Weinreich & Birgitte Schantz Laursen. (2020) COPD Patients’ Experience of Long-Term Domestic Oxygen-Enriched Nasal High Flow Treatment: A Qualitative Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 175-183.
Read now
Read now
Nurdan Kokturk, Wael Abuharbid, Amr S Albanna, Hakan Gunen, Alev Gurgun, Mousa Khadadah, Elmas Malvolti, Medhat Soliman, Richard van Zyl-Smit, Noureddine Zidouni & Ashraf Alzaabi. (2019) A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2959-2970.
Read now
Read now
Mi-Ae Kim, Min-Kang Suh, Jisoo Park, Jung-Hyun Kim, Tae-Hoon Kim, Eun Kyung Kim, Yeon-Mok Oh, Sang-Do Lee & Ji-Hyun Lee. (2019) Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2135-2144.
Read now
Read now
Ioanna Tsiligianni, Maria Kampouraki, Despo Ierodiakonou, Ioannis Poulonirakis & Polyvios Papadokostakis. (2019) COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 547-556.
Read now
Read now
Marco Basile, Pierpaolo Baiamonte, Emilia Mazzuca, Stefania Principe, Federica Pennavaria, Alida Benfante & Nicola Scichilone. (2018) Sleep Disturbances in COPD are Associated with Heterogeneity of Airway Obstruction. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:4, pages 350-354.
Read now
Read now
Kate M Johnson, Abdollah Safari, Wan C Tan, Jean Bourbeau, J Mark FitzGerald, Mohsen Sadatsafavi & On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) study. (2018) Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3983-3995.
Read now
Read now
Alexa Núñez, Cristina Esquinas, Miriam Barrecheguren, Myriam Calle, Ricard Casamor & Marc Miravitlles. (2018) Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3837-3844.
Read now
Read now
Anna Muñoz, Mark Small, Robert Wood, Anna Ribera & Javier Nuevo. (2018) The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1557-1568.
Read now
Read now
Johannes Krönig, Olaf Hildebrandt, Andreas Weissflog, Werner Cassel, Volker Gross, Keywan Sohrabi, Patrick Fischer & Ulrich Koehler. (2017) Long-term Recording of Night-Time Respiratory Symptoms in Patients with Stable COPD II–IV. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 498-503.
Read now
Read now
Amanda R van Buul, Marise J Kasteleyn, Niels H Chavannes & Christian Taube. (2017) The association between objectively measured physical activity and morning symptoms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2831-2840.
Read now
Read now
Bo Ding, Marco DiBonaventura, Niklas Karlsson, Gina Bergström & Ulf Holmgren. (2017) A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 529-539.
Read now
Read now
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Morning symptoms in COPD: a treatable yet often overlooked factor. Expert Review of Respiratory Medicine 11:4, pages 311-322.
Read now
Read now
Yogesh Suresh Punekar, Ian Naya, Mark Small, Tim Holbrook, Robert Wood, Hana Mullerova & Manuel Valle. (2017) Bronchodilator reliever use and its association with the economic and humanistic burden of COPD: a propensity-matched study. Journal of Medical Economics 20:1, pages 28-36.
Read now
Read now
Emilie Chan-Thim, Marie Dumont, Gregory Moullec, Zohra Parwanta, Barbara Trutschnigg, Jean Paquet & Veronique Pepin. (2016) Amplitude of the rest–activity cycle in chronic obstructive pulmonary disease: an exploratory study. ChronoPhysiology and Therapy 6, pages 75-83.
Read now
Read now
Marc Miravitlles, Heinrich Worth, Juan José Soler-Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina S. Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés & Anna Ribera. (2016) The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS). COPD: Journal of Chronic Obstructive Pulmonary Disease 13:5, pages 561-568.
Read now
Read now
Wei-Chun Lin, Tsuey-Yuan Huang, Chieh-Yu Liu, Mei-Ling Yeh, Chia-Hui Yu & Shiow-Li Hwang. (2016) Validation of the Clinical COPD Questionnaire in Taiwan. COPD: Journal of Chronic Obstructive Pulmonary Disease 13:3, pages 360-366.
Read now
Read now
Maria Gabriella Matera, Alessandro Sanduzzi & Mario Cazzola. (2016) Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 73-79.
Read now
Read now
Marco Contoli, Paolo Solidoro, Fabiano Di Marco, Nicola Scichilone, Angelo Corsico, Fulvio Braido & Pierachille Santus. (2016) Effects of aclidinium on determinants of COPD severity: symptoms and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3043-3050.
Read now
Read now
Marc Miravitlles, Kenneth R Chapman, Ferran Chuecos, Anna Ribera & Esther Garcia Gil. (2016) The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2041-2053.
Read now
Read now
Jose M Marin, Kai M Beeh, Andreas Clemens, Walter Castellani, Lennart Schaper, Dinesh Saralaya, Anthony Gunstone, Ricard Casamor, Konstantinos Kostikas & Maryam Aalamian-Mattheis. (2016) Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING). International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1425-1434.
Read now
Read now
Michele Vitacca, Mara Paneroni, Paola Baiardi, Vito De Carolis, Elisabetta Zampogna, Stefano Belli, Mauro Carone, Antonio Spanevello, Bruno Balbi & Giorgio Bertolotti. (2016) Development of a Barthel Index based on dyspnea for patients with respiratory diseases. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1199-1206.
Read now
Read now
Gregory Feldman, François Maltais, Sanjeev Khindri, Mitra Vahdati-Bolouri, Alison Church, William A Fahy & Roopa Trivedi. (2016) A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 719-730.
Read now
Read now
Paul W Jones, Henrik Watz, Emiel FM Wouters & Mario Cazzola. (2016) COPD: the patient perspective. International Journal of Chronic Obstructive Pulmonary Disease 11:sup1, pages 13-20.
Read now
Read now
Jose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, Maria Isabel Asensio-Cruz, Eduardo Márquez-Martín & Francisco Ortega-Ruiz. (2015) Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Preference and Adherence 9, pages 95-104.
Read now
Read now
Tony D’Urzo, James F Donohue, David Price, Marc Miravitlles & Edward Kerwin. (2015) Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:5, pages 519-532.
Read now
Read now
Judith J Stephenson, Qian Cai, Michelle Mocarski, Hiangkiat Tan, Jalpa A Doshi & Sean D Sullivan. (2015) Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 577-586.
Read now
Read now
Michelle Mocarski, Erica Zaiser, Dylan Trundell, Barry J Make & Asha Hareendran. (2015) Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 475-487.
Read now
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2014) Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 15:7, pages 961-977.
Read now
Read now
Jean Bourbeau, Wan C. Tan, Andrea Benedetti, Shawn D. Aaron, Kenneth R. Chapman, Harvey O. Coxson, Robert Cowie, Mark Fitzgerald, Roger Goldstein, Paul Hernandez, Jonathon Leipsic, Francois Maltais, Darcy Marciniuk, Denis O’Donnell, Don D. Sin & for the CanCOLD study group. (2014) Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:2, pages 125-132.
Read now
Read now
Anthony D’Urzo, Edward Kerwin, Tim Overend, Peter D’Andrea, Hungta Chen & Pankaj Goyal. (2014) Once daily glycopyrronium for the treatment of COPD: pooled analysis of the GLOW1 and GLOW2 studies. Current Medical Research and Opinion 30:3, pages 493-508.
Read now
Read now
Philip O’Hagan & Niels H. Chavannes. (2014) The impact of morning symptoms on daily activities in chronic obstructive pulmonary disease. Current Medical Research and Opinion 30:2, pages 301-314.
Read now
Read now
Nicolas Roche, Mark Small, Sarah Broomfield, Victoria Higgins & Ryan Pollard. (2013) Real World COPD: Association of Morning Symptoms with Clinical and Patient Reported Outcomes. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:6, pages 679-686.
Read now
Read now
M Decramer, G Brusselle, J Buffels, JL Corhay, W De Backer, JM Degryse, W Janssens, E Marchand, P Van den Brande, W Vincken, G Gayan-Ramirez, V Van Craenendonck, H Vandenberghe & P De Vuyst. (2013) COPD AWARENESS SURVEY: DO BELGIAN PULMONARY PHYSICIANS COMPLY WITH THE GOLD GUIDELINES 2010?. Acta Clinica Belgica 68:5, pages 325-340.
Read now
Read now
Mathieu Molimard & Peter D’Andrea. (2013) Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile. Expert Review of Clinical Pharmacology 6:5, pages 503-517.
Read now
Read now
Jutta Beier, Anne-Marie Kirsten, Robert Mróz, Rosa Segarra, Ferran Chuecos, Cynthia Caracta & Esther Garcia Gil. (2013) Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:4, pages 511-522.
Read now
Read now
Cristina Jácome, Alda Marques, Raquel Gabriel & Daniela Figueiredo. (2013) Chronic obstructive pulmonary disease and functioning: implications for rehabilitation based on the ICF framework. Disability and Rehabilitation 35:18, pages 1534-1545.
Read now
Read now
Thys van der Molen, Marc Miravitlles & Janwillem WH Kocks. (2013) COPD management: role of symptom assessment in routine clinical practice. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 461-471.
Read now
Read now
David Price, Mark Small, Gary Milligan, Victoria Higgins, Esther Garcia Gil & Jordi Estruch. (2013) Impact of night-time symptoms in COPD: a real-world study in five European countries. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 595-603.
Read now
Read now
Jose Luis Lopez-Campos, Carmen Calero & Esther Quintana-Gallego. (2013) Symptom variability in COPD: a narrative review. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 231-238.
Read now
Read now
Mario Cazzola, Clive P Page & Maria Gabriella Matera. (2013)
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:9, pages 1205-1214.
Read now
Read now
Shiva Sadeghi, Dina Brooks, Shelley Stagg-Peterson & Roger Goldstein. (2013) Growing Awareness of the Importance of Health Literacy in Individuals with COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:1, pages 72-78.
Read now
Read now
Pascale Salameh, Georges Khayat & Mirna Waked. (2012) Could symptoms and risk factors diagnose COPD? Development of a Diagnosis Score for COPD. Clinical Epidemiology 4, pages 247-255.
Read now
Read now
Anthony D'Urzo & Claus Vogelmeier. (2012) Future of chronic obstructive pulmonary disease management. Expert Review of Respiratory Medicine 6:3, pages 285-299.
Read now
Read now
Edward M. Kerwin, Anthony D. D'Urzo, Arthur F. Gelb, Hassan Lakkis, Esther Garcia Gil & Cynthia F. Caracta. (2012) Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I). COPD: Journal of Chronic Obstructive Pulmonary Disease 9:2, pages 90-101.
Read now
Read now
Roland Buhl & Donald Banerji. (2012) Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 729-741.
Read now
Read now
Marcos Ribeiro & Kenneth R Chapman. (2012) Comparative efficacy of indacaterol in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 7, pages 145-152.
Read now
Read now
Eugene R Bleecker, Thomas Siler, Roger Owen & Benjamin Kramer. (2011) Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data. International Journal of Chronic Obstructive Pulmonary Disease 6, pages 431-438.
Read now
Read now
Articles from other publishers (90)
Manuel Castillejos-López, Yair Romero, Angelica Varela-Ordoñez, Edgar Flores-Soto, Bianca S. Romero-Martinez, Rafael Velázquez-Cruz, Joel Armando Vázquez-Pérez, Víctor Ruiz, Juan C. Gomez-Verjan, Nadia A. Rivero-Segura, Ángel Camarena, Ana Karen Torres-Soria, Georgina Gonzalez-Avila, Bettina Sommer, Héctor Solís-Chagoyán, Ruth Jaimez, Luz María Torres-Espíndola & Arnoldo Aquino-Gálvez. (2023) Hypoxia Induces Alterations in the Circadian Rhythm in Patients with Chronic Respiratory Diseases. Cells 12:23, pages 2724.
Crossref
Crossref
Maria Gabriella Matera, Barbara Rinaldi, Concetta Ambrosio & Mario Cazzola. (2023) Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?. Respiratory Medicine 219, pages 107439.
Crossref
Crossref
Jiankang Wu, Weiwei Meng, Huihui Zeng, Yiming Ma & Yan Chen. (2023) Relationship between nighttime symptoms and clinical features in COPD patients: A cross-sectional multicenter study in China. Heart & Lung 62, pages 168-174.
Crossref
Crossref
Beatriz Raboso Moreno, Cristina López Riolobos, José María Díaz-García, Cristina Matesanz López & Araceli Abad Fernández. (2023) Influence of Chronotypes in Respiratory Pathology. Open Respiratory Archives 5:1, pages 100228.
Crossref
Crossref
Bernie Y. Sunwoo & Robert L. Owens. (2022) Sleep Deficiency, Sleep Apnea, and Chronic Lung Disease. Clinics in Chest Medicine 43:2, pages 337-352.
Crossref
Crossref
Radhika R, Beena Thomas, Ahmed Rafad, Jerin James, Mekha Monsi Chenthiyethu & Ruben Thomas Lal. (2022) A study on the safety profile and clinical outcomes in patients using tulobuterol transdermal patch as an add on therapy in stable chronic obstructive pulmonary disease. IP Indian Journal of Immunology and Respiratory Medicine 7:1, pages 16-20.
Crossref
Crossref
Hanna Sandelowsky, Ulla Møller Weinreich, Bernt B. Aarli, Josefin Sundh, Kristian Høines, Georgios Stratelis, Anders Løkke, Christer Janson, Christian Jensen & Kjell Larsson. (2021) COPD – do the right thing. BMC Family Practice 22:1.
Crossref
Crossref
A. F. Davey, J. Coombes, I. Porter, C. Green, A. J. Mewse & J. M. Valderas. (2021) Development of a conceptual model for research on cyclical variation of patient reported outcome measurements (PROMs) in patients with chronic conditions: a scoping review. Journal of Patient-Reported Outcomes 5:1.
Crossref
Crossref
Eidelman Antonio González-Mejía, Olga Constanza Uñate-Suárez, Carlos José Bula Gutiérrez & Yojana Patricia Patiño-Jiménez. (2021) Variability of symptoms in outpatients with COPD and validation of the Colombian instrument for symptoms variability in COPD (CoVaSy). Revista de la Facultad de Medicina 69:4, pages e79817.
Crossref
Crossref
John R. Hurst, Tonya Winders, Heinrich Worth, Mohit Bhutani, Kevin Gruffydd-Jones, Daiana Stolz & Mark T. Dransfield. (2020) A Patient Charter for Chronic Obstructive Pulmonary Disease. Advances in Therapy 38:1, pages 11-23.
Crossref
Crossref
Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu & David Bernstein. (2020) Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials. Respiratory Research 21:1.
Crossref
Crossref
Fabrice Mowbray, Manaf Zargoush, Aaron Jones, Kerstin de Wit & Andrew Costa. (2020) Predicting hospital admission for older emergency department patients: Insights from machine learning. International Journal of Medical Informatics 140, pages 104163.
Crossref
Crossref
Mark T. Dransfield, Justin L. Garner, Surya P. Bhatt, Dirk-Jan Slebos, Karin Klooster, Frank C. Sciurba, Pallav L. Shah, Nathaniel T. Marchetti, Richard D. Sue, Shawn Wright, Hiram Rivas-Perez, Tanya A. Wiese, Momen M. Wahidi, Hugo Goulart de Oliveira, Brian Armstrong, Sri Radhakrishnan, Narinder S. Shargill, Gerard J. Criner, Lewis Katz, Gerard J. Criner, Gerard J. Criner, Francis Cordova, Parag Desai, Nathaniel Marchetti, Victor Kim, Kartik Shenoy, John Travaline, Jiji Thomas, Lii-Yoong H. Criner, Richard Sue, Shawn Wright, Aaron Thornburg, Terry Thomas, Mark Dransfield, Surya Bhatt, James Michael Wells, Necole Seabron-Harris, Hiram Rivas-Perez, Umair Gauhar, Tanya A. Wiese, Crissie Despirito, Frank Sciurba, Jessica Bon Field, Divay Chandra, Joseph Leader, Roy Semaan, Christina Ledezma, Pallav Shah, Samuel Kemp, Justin Garner, Arafa Aboelhassan, Karthi Srikanthan, Eric Tenda, Anita Abraham, Cai Sim, Momen Wahidi, Kamran Mahmood, Scott Shofer, Kathleen Coles, Hugo Goulart de Oliveira, Guilherme Augusto Oliveira, Betina Machado, Igor Benedetto, Fabio Svartman, Amarilio de Macedo Neto, Leonardo Schreiner, Taiane Vieira, Brian Morrissey, Ken Yoneda, Tina Tham, Daniel Tompkins, Paulo F. Guerreiro Cardoso, Rodrigo Athanazio, Felipe Nominando, Samia Rached, Luciana Cassimiro, Steven Hays, Eric Seeley, Pavan Shrestha, Gabriela R. Dincheva, Adnan Majid, Daniel Alape-Moya, Mihir Parikh, Alichia Paton, Alexis Agnew, Nicholas PastisJr.Jr., Charlie Strange, Tatsiana Beiko, Danielle Woodford, Mary Blanton, Lisa Kopas, Timothy Connolly, Jose Fernando Santacruz, Bhavin Shah, Mark Vollenweider, Luis Herrera, Rumi Khan, Kristine Sernulka, P. Michael McFadden, Richard Barbers, Michelle Hernandez, Michael Machuzak, Francisco Almeida, Joseph Cicenia, Thomas Gildea, Atul Mehta, Sonali Sethi, Yvonne Meli, David Hsia, Richard Casaburi, William Stringer, Leticia Diaz, Arthur Sung, Meghan Ramsey, Ryan Van Wert, Karen Morris, Nabil Jarad, Tim Batchelor, Iara Sequeiros, Katy Tucker, Malgorzata Kornaszweska, Hazem Fallouh, Ramsey Sabit, Hatam Naase, Joseph George, Azin Salimian, Helen Dyer, Stephen Hazelrigg, Kristal Adams, Karen Bade, Ganesh Krishna, Bryan S. Benn, Michelle Canfield, Sharmila Vetri Villalan, Travis Stewart, Dirk-Ja n Slebos, Nick H. T. ten Hacken, Karin Klooster, Jorine Hartman & Sonja Augustijn. (2020) Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial. Annals of the American Thoracic Society 17:7, pages 829-838.
Crossref
Crossref
Ioanna Tsiligianni & Janwillem W. H. Kocks. (2020) Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. npj Primary Care Respiratory Medicine 30:1.
Crossref
Crossref
Marco Contoli, Simonetta Baraldo, Valentina Conti, Giulia Gnesini, Brunilda Marku, Paolo Casolari, Paola Scrigner, Paolo Morelli, Marina Saetta, Antonio Spanevello & Alberto Papi. (2019) Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof‐of‐concept cohort study. Respirology 25:1, pages 80-88.
Crossref
Crossref
Florin Mihaltan, Yochai Adir, Adam Antczak, Konstantinos Porpodis, Vesna Radulovic, Nuno Pires, Geeuwke Jan de Vries, Andreas Horner, Samuel De Bontridder, Yunqin Chen, Anat Shavit, Silviu Alecu & Lukasz Adamek. (2019) Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study. Respiratory Research 20:1.
Crossref
Crossref
Raffaele Antonelli Incalzi, Giorgio Walter Canonica, Nicola Scichilone, Sara Rizzoli, Lucia Simoni & Francesco Blasi. (2019) The COPD multi-dimensional phenotype: A new classification from the STORICO Italian observational study. PLOS ONE 14:9, pages e0221889.
Crossref
Crossref
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2018) Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms. Respiratory Research 19:1.
Crossref
Crossref
Maochun Wu, Zequan Wang, Manman Li & Kun Li. (2017) Daily Symptom Variability in Patients With Stable COPD: A Narrative Review. Western Journal of Nursing Research 40:10, pages 1543-1561.
Crossref
Crossref
Marc Miravitlles, Ana Menezes, Maria Victorina López Varela, Alejandro Casas, Luis Ugalde, Alejandra Ramirez-Venegas, Laura Mendoza, Ana López, Fernando C. Wehrmeister, Filip Surmont & Maria Montes de Oca. (2018) Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study. Respiratory Medicine 134, pages 62-69.
Crossref
Crossref
Maria Comas, Christopher J. Gordon, Brian G. Oliver, Nicholas W. Stow, Gregory King, Pawan Sharma, Alaina J. Ammit, Ronald R. Grunstein & Craig L. Phillips. (2017) A circadian based inflammatory response – implications for respiratory disease and treatment. Sleep Science and Practice 1:1.
Crossref
Crossref
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser, James Krainson, Luis Delacruz, Samir Arora, Gregory Feldman, Krishna Pudi, Shahid Siddiqui, Chad Orevillo, Andrea Maes, Earl St. Rose & Ubaldo Martin. (2017) 24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD. Respiratory Research 18:1.
Crossref
Crossref
Marc Miravitlles & Anna Ribera. (2017) Understanding the impact of symptoms on the burden of COPD. Respiratory Research 18:1.
Crossref
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Crossref
Colin Reisner, Leonardo M. Fabbri, Edward M. Kerwin, Charles Fogarty, Selwyn Spangenthal, Klaus F. Rabe, Gary T. Ferguson, Fernando J. Martinez, James F. Donohue, Patrick Darken, Earl St. Rose, Chad Orevillo, Shannon Strom, Tracy Fischer, Michael Golden & Sarvajna Dwivedi. (2017) A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref
Hiroyuki Ohbayashi. (2017) Comparison of the rapid effects of single inhalations of formoterol and tiotropium bromide on respiratory function and COPD symptoms in a randomized crossover study. Respiratory Investigation 55:6, pages 348-356.
Crossref
Crossref
G.W. Canonica, F. Blasi, N. Scichilone, L. Simoni, A. Zullo, C. Giovannetti, C. Briguglio, S. Barsanti & R. Antonelli Incalzi. (2017) Characterization of circadian COPD symptoms by phenotype: Methodology of the STORICO observational study. European Journal of Internal Medicine 43, pages 62-68.
Crossref
Crossref
Marc Miravitlles, José Luis Izquierdo, Cristina Esquinas, Maite Pérez, Myriam Calle, José Luis López-Campos, José Miguel Rodríguez González-Moro, Ciro Casanova, Cristóbal Esteban & Pilar de Lucas. (2017) The variability of respiratory symptoms and associated factors in COPD. Respiratory Medicine 129, pages 165-172.
Crossref
Crossref
Sohita Dhillon. (2017) Extrafine beclometasone dipropionate/formoterol fumarate metered-dose and dry-powder inhalers in asthma and chronic obstructive pulmonary disease: a profile of their use. Drugs & Therapy Perspectives 33:6, pages 260-271.
Crossref
Crossref
Kesavan Suresh Babu & Jaymin Bhagwanji Morjaria. (2017) Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy. Therapeutic Advances in Chronic Disease 8:4-5, pages 81-91.
Crossref
Crossref
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Association between morning symptoms and physical activity in COPD: a systematic review. European Respiratory Review 26:143, pages 160033.
Crossref
Crossref
Dave Singh, Marc Miravitlles & Claus Vogelmeier. (2016) Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Advances in Therapy 34:2, pages 281-299.
Crossref
Crossref
Gary Globe, Brooke Currie, Nancy Kline Leidy, Paul Jones, David Mannino, Fernando Martinez, Paul Klekotka, Sean O’Quinn, Niklas Karlsson & Ingela Wiklund. (2016) Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD). Health and Quality of Life Outcomes 14:1.
Crossref
Crossref
M. G. H. Dekker-van Weering, M. M. R. Vollenbroek-Hutten & H. J. Hermens. (2016) Adherence to an online exercise program for COPD patients in the home environment- a pilot study. Health and Technology 6:4, pages 259-268.
Crossref
Crossref
S. Vamsee Raju, Hyunki Kim, Stephen A. Byzek, Li Ping Tang, John E. Trombley, Patricia Jackson, Lawrence Rasmussen, J. Michael Wells, Emily Falk Libby, Erik Dohm, Lindy Winter, Sharon L. Samuel, Kurt R. Zinn, J. Edwin Blalock, Trenton R. Schoeb, Mark T. Dransfield & Steven M. Rowe. (2016) A ferret model of COPD-related chronic bronchitis. JCI Insight 1:15.
Crossref
Crossref
Ioanna Tsiligianni, Esther Metting, Thys van der Molen, Niels Chavannes & Janwillem Kocks. (2016) Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Juan José Soler-Cataluña, Jaume Sauleda, Luis Valdés, Pilar Marín, Ramón Agüero, Maite Pérez & Marc Miravitlles. (2016) Prevalencia y percepción de la variabilidad diaria de los síntomas en pacientes con enfermedad pulmonar obstructiva crónica estable en España. Archivos de Bronconeumología 52:6, pages 308-315.
Crossref
Crossref
Juan José Soler-Cataluña, Jaume Sauleda, Luis Valdés, Pilar Marín, Ramón Agüero, Maite Pérez & Marc Miravitlles. (2016) Prevalence and Perception of 24-h Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain. Archivos de Bronconeumología (English Edition) 52:6, pages 308-315.
Crossref
Crossref
Eric D. Bateman, Kenneth R. Chapman, Dave Singh, Anthony D. D’Urzo, Eduard Molins, Anne Leselbaum & Esther Garcia Gil. (2015) Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respiratory Research 16:1.
Crossref
Crossref
Björn Laudahn & Sören Schmidtmann. (2015) Wie praxisrelevant sind die GOLD-Empfehlungen für den ambulanten Alltag bei COPD?. Pneumo News 7:5, pages 53-59.
Crossref
Crossref
Jutta Beier. (2015) A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of chronic obstructive pulmonary disease. Clinical Investigation 5:8, pages 691-700.
Crossref
Crossref
Adam P Garrow, Naimat Khan, Sarah Tyson, Jørgen Vestbo, Dave Singh & Janelle Yorke. (2015) The development and first validation of the Manchester Early Morning Symptoms Index (MEMSI) for patients with COPD. Thorax 70:8, pages 757-763.
Crossref
Crossref
Michael H. Smolensky, Francesco Portaluppi, Roberto Manfredini, Ramon C. Hermida, Ruana Tiseo, Linda L. Sackett-Lundeen & Erhard L. Haus. (2015) Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Medicine Reviews 21, pages 3-11.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2015) Aclidinium bromide/formoterol fumarate dry-powder inhaler: a guide to its use in chronic obstructive pulmonary disease in the EU. Drugs & Therapy Perspectives 31:6, pages 183-189.
Crossref
Crossref
Katharina Marth, Elisabeth Schuller & Wolfgang Pohl. (2015) Improvements in patient-reported outcomes: A prospective, non-interventional study with aclidinium bromide for treatment of COPD. Respiratory Medicine 109:5, pages 616-624.
Crossref
Crossref
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman. (2014) Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials. Clinical Investigation 4:12, pages 1095-1111.
Crossref
Crossref
Anthony D D’Urzo, Stephen I Rennard, Edward M Kerwin, Victor Mergel, Anne R Leselbaum & Cynthia F Caracta. (2014) Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respiratory Research 15:1.
Crossref
Crossref
Marc Miravitlles, Heinrich Worth, Juan José Soler Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina Skavlan Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés & Anna Ribera. (2014) Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respiratory Research 15:1.
Crossref
Crossref
Claudio M Sanguinetti, Fernando De Benedetto, Claudio F Donner, Stefano Nardini & Alberto Visconti. (2014) Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Claudio M Sanguinetti. (2014) The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Dave Singh, Gabriele Nicolini, Eddi Bindi, Massimo Corradi, Daniele Guastalla, Jorg Kampschulte, Władysław Pierzchała, Abdullah Sayiner, Mária Szilasi, Claudio Terzano & Jørgen Vestbo. (2014) Extrafine Beclomethasone/formoterol compared to Fluticasone/salmeterol Combination Therapy in COPD. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Kenneth R Chapman, Kai-Michael Beeh, Jutta Beier, Eric D Bateman, Anthony D’Urzo, Robert Nutbrown, Michelle Henley, Hungta Chen, Tim Overend & Peter D’Andrea. (2014) A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Dave Singh, Paul W Jones, Eric D Bateman, Stephanie Korn, Cristina Serra, Eduard Molins, Cynthia Caracta, Esther Garcia Gil & Anne Leselbaum. (2014) Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study. BMC Pulmonary Medicine 14:1.
Crossref
Crossref
Stefan Köberich, Christa Lohrmann & Theo Dassen. (2014) Care dependency in patients with chronic obstructive pulmonary disease and heart failure - a secondary data analysis of German prevalence studies. Scandinavian Journal of Caring Sciences 28:4, pages 665-674.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2014) Formoterol/budesonide pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease. Drugs & Therapy Perspectives 30:8, pages 269-275.
Crossref
Crossref
N K Leidy, C C Sexton, P W Jones, S M Notte, B U Monz, L Nelsen, M Goldman, L T Murray & S Sethi. (2014) Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax 69:5, pages 424-430.
Crossref
Crossref
Alexandre Trifilieff, Steven J. Charlton & Robin A. Fairhurst. 2014. Indacaterol. Indacaterol
25
37
.
Asha Hareendran, Andrew C Palsgrove, Michelle Mocarski, Michael L Schaefer, Juliana Setyawan, Robyn Carson & Barry Make. (2013) The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health and Quality of Life Outcomes 11:1.
Crossref
Crossref
Pascale Salameh, Georges Khayat & Mirna Waked. (2013) Diagnostic score for COPD: Validation of the DS-COPD in clinical settings. Clinical Epidemiology and Global Health 1:3, pages 107-114.
Crossref
Crossref
A. Prakash, K.S. Babu & J.B. Morjaria. (2013) Novel anti-cholinergics in COPD. Drug Discovery Today 18:21-22, pages 1117-1126.
Crossref
Crossref
C. Compton, D. McBryan, E. Bucchioni & F. Patalano. (2013) The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics 26:5, pages 562-573.
Crossref
Crossref
J Andrew Woods, Kimberly L Nealy & Robert W Barrons. (2013) Aclidinium Bromide: An Alternative Long-Acting Inhaled Anticholinergic in the Management of Chronic Obstructive Pulmonary Disease. Annals of Pharmacotherapy 47:7-8, pages 1017-1028.
Crossref
Crossref
Yoshinosuke Fukuchi, Ronnie Samoro, Rustem Fassakhov, Hiroyuki Taniguchi, Jan Ekelund, Lars-Goran Carlsson & Masakazu Ichinose. (2013) Budesonide/formoterol via Turbuhaler® versus formoterol via Turbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: Phase III multinational study results. Respirology 18:5, pages 866-873.
Crossref
Crossref
Mario Cazzola, Clive Page & Maria Gabriella Matera. (2013) Long-acting muscarinic receptor antagonists for the treatment of respiratory disease. Pulmonary Pharmacology & Therapeutics 26:3, pages 307-317.
Crossref
Crossref
Giovanni Pisa, Siegfried Freytag & Rainer Schandry. (2013) Chronic Obstructive Pulmonary Disease (COPD) Patients’ Disease-Related Preferences. The Patient - Patient-Centered Outcomes Research 6:2, pages 93-101.
Crossref
Crossref
A. Gillissen. (2013) Die guten und die schlechten Tage der COPD-Patienten. MMW - Fortschritte der Medizin 155:4, pages 53-55.
Crossref
Crossref
Thierry Troosters, Thys van der Molen, Michael Polkey, Roberto A Rabinovich, Ioannis Vogiatzis, Idelle Weisman & Karoly Kulich. (2013) Improving physical activity in COPD: towards a new paradigm. Respiratory Research 14:1, pages 115.
Crossref
Crossref
Nicolas Roche, Niels H Chavannes & Marc Miravitlles. (2013) COPD symptoms in the morning: impact, evaluation and management. Respiratory Research 14:1, pages 112.
Crossref
Crossref
Sophie C. Timmins, Nicholas Coatsworth, Gaurie Palnitkar, Cindy Thamrin, Catherine E. Farrow, Robin E. Schoeffel, Norbert Berend, Chantale Diba, Cheryl M. Salome & Gregory G. King. (2013) Day-to-day variability of oscillatory impedance and spirometry in asthma and COPD. Respiratory Physiology & Neurobiology 185:2, pages 416-424.
Crossref
Crossref
Shannon Cope, Jie Zhang, James Williams & Jeroen P Jansen. (2012) Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis. BMC Pulmonary Medicine 12:1.
Crossref
Crossref
François Maltais & Julie Milot. (2012) The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 6:6, pages 345-361.
Crossref
Crossref
Shannon Cope, Gorana Capkun-Niggli, Rupert Gale, Cheryl Lassen, Roger Owen, Mario J.N.M. Ouwens, Gert Bergman & Jeroen P. Jansen. (2012) Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD: A Patient-Level Mixed Treatment Comparison. Value in Health 15:3, pages 524-533.
Crossref
Crossref
Mario Cazzola, Pierluigi Paggiaro, Paolo Palange, Leif Bjermer, Pilar Ausin, Lars-Goran Carlsson, Jan Ekelund & Jan Lotvall. (2012) Onset of Action of Formoterol versus Salmeterol via Dry Powder Inhalers in Moderate Chronic Obstructive Pulmonary Disease. Clinical Drug Investigation 32:3, pages 147-155.
Crossref
Crossref
Rainard Fuhr, Helgo Magnussen, Kristina Sarem, Anna Ribera Llovera, Anne-Marie Kirsten, Meritxell Falqués, Cynthia F. Caracta & Esther Garcia Gil. (2012) Efficacy of Aclidinium Bromide 400 μg Twice Daily Compared With Placebo and Tiotropium in Patients With Moderate to Severe COPD. Chest 141:3, pages 745-752.
Crossref
Crossref
Yeon Jae KimByung Ki LeeChi Young JungYoung June JeonDae Sung HyunKyung Chan KimSung Ken YuHye Sook ChoiWon Hyuk ShinKwan Ho Lee. (2012) Patient's Perception of Symptoms Related to Morning Activity in Chronic Obstructive Pulmonary Disease: The SYMBOL Study. The Korean Journal of Internal Medicine 27:4, pages 426.
Crossref
Crossref
Maarten van den Berge, Wim CJ Hop, Thys van der Molen, Jan A van Noord, Jacques PHM Creemers, Ad JM Schreurs, Emiel FM Wouters & Dirkje S Postma. (2012) Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respiratory Research 13:1, pages 44.
Crossref
Crossref
María José Espinosa de los Monteros, Carolina Peña, Enrique Javier Soto Hurtado, Javier Jareño & Marc Miravitlles. (2012) Variabilidad de los síntomas respiratorios en la EPOC grave. Archivos de Bronconeumología 48:1, pages 3-7.
Crossref
Crossref
María José Espinosa de los Monteros, Carolina Peña, Enrique Javier Soto Hurtado, Javier Jareño & Marc Miravitlles. (2012) Variability of Respiratory Symptoms in Severe COPD. Archivos de Bronconeumología (English Edition) 48:1, pages 3-7.
Crossref
Crossref
Anouk W. Vaes, Emiel F.M. Wouters, Frits M.E. Franssen, Nicole H.M.K. Uszko-Lencer, Koen H.P. Stakenborg, Marlies Westra, Kenneth Meijer, Annemie M.W.J. Schols, Paul P. Janssen & Martijn A. Spruit. (2011) Task-Related Oxygen Uptake During Domestic Activities of Daily Life in Patients With COPD and Healthy Elderly Subjects. Chest 140:4, pages 970-979.
Crossref
Crossref
Claus Vogelmeier, Helgo Magnussen, Craig LaForce, Roger Owen & Benjamin Kramer. (2011)
Profiling the bronchodilator effects of the novel ultra-long-acting β
2
-agonist indacaterol against established treatments in chronic obstructive pulmonary disease
. Therapeutic Advances in Respiratory Disease 5:5, pages 345-357.
Crossref
Crossref
A. Agusti, J. Hedner, J.M. Marin, F. Barbé, M. Cazzola & S. Rennard. (2011) Night-time symptoms: a forgotten dimension of COPD. European Respiratory Review 20:121, pages 183-194.
Crossref
Crossref
Bartolome R. Celli, Donald P. Tashkin, Stephen I. Rennard, Jennifer McElhattan & Ubaldo J. Martin. (2011) Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. Respiratory Medicine 105:8, pages 1176-1188.
Crossref
Crossref
Kenneth R. Chapman, Stephen I. Rennard, Angeli Dogra, Roger Owen, Cheryl Lassen & Benjamin Kramer. (2011) Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD. Chest 140:1, pages 68-75.
Crossref
Crossref
Stephanie Korn, Edward Kerwin, Sibel Atis, Carolynn Amos, Roger Owen & Cheryl Lassen. (2011) Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study. Respiratory Medicine 105:5, pages 719-726.
Crossref
Crossref
Heinrich Worth, Karin Förster, Göran Eriksson, Ulf Nihlén, Stefan Peterson & Helgo Magnussen. (2010) Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respiratory Medicine 104:10, pages 1450-1459.
Crossref
Crossref
James F. Donohue, Charles Fogarty, Jan Lötvall, Donald A. Mahler, Heinrich Worth, Arzu Yorgancioğlu, Amir Iqbal, James Swales, Roger Owen, Mark Higgins & Benjamin Kramer. (2010) Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 182:2, pages 155-162.
Crossref
Crossref
. (2010) Current World Literature. Current Opinion in Supportive & Palliative Care 4:2, pages 111-120.
Crossref
Crossref
José Luis López-Campos. (2010) Importancia y variabilidad de los síntomas en la EPOC. Su importancia para el tratamiento. Archivos de Bronconeumología 46, pages 20-24.
Crossref
Crossref
Tobias Welte, Marc Miravitlles, Paul Hernandez, Göran Eriksson, Stefan Peterson, Tomasz Polanowski & Romain Kessler. (2009) Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 180:8, pages 741-750.
Crossref
Crossref
Martyn R. PartridgeWolfgang Schuermann, Ola Beckman, Tore Persson & Tomasz Polanowski. (2009) Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Therapeutic Advances in Respiratory Disease 3:4, pages 147-157.
Crossref
Crossref